IMR Press / RCM / Special Issues / genetic_polymorphism_and_CAD

Genetic Polymorphism and Coronary Artery Disease

Submission deadline: 29 February 2024
Special Issue Editors
  • Xiang Xie, PhD
    Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China
    Interests: coronary artery disease; cardiovascular risk; hypertension; genetic polymorphism; myocardial infarction; cardiovascular medicine; coronary angiography; PCI
  • Ying-Ying Zheng, PhD
    Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China
    Interests: cardiomyopathy; heart failure; coronary heart disease; arrhythmia; metabolic heart disease; oncocardiology; genetic polymorphism
Special Issue Information

Dear Colleagues,

Coronary artery disease is a result of the interaction between environmental factors and genetics. This Special Issue will focus on the latest advances in the association of genetics with coronary artery disease. It has been established that polymorphisms of several genes are involved in lipid metabolism, thrombosis, and inflammatory pathways. Genetic biomarkers (i.e. gene polymorphisms) may be especially helpful in risk prediction, prognosis, or prediction of treatment response in patients with coronary artery disease. The impact of genetic polymorphisms on outcomes of coronary artery disease is still insufficiently understood and well-designed prospective randomized clinical trials are needed to properly address the role of genetic polymorphisms. Personalized or precision medicine will most probably play an important role in managing subjects at increased risk for CAD according to clinical and genetic information, providing that genetic tests (i.e. cost) become more widely available and that the genetic markers be confirmed in prospective studies. We welcome original clinical, pre-clinical or basic research papers. Reviews that identify problems or challenges, present a dedicated overview or provide solutions or prospects will also be considered.

Prof. Xiang Xie and Dr. Ying-Ying Zheng
Guest Editors

Keywords
genetics polymorphism
coronary artery disease
personalized medicine
precision medicine
Manuscript Submission Information

Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 2200 USD. Submitted manuscripts should be well formatted in good English.

Back to top